Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction

被引:14
|
作者
Steiner, Johannes [1 ,2 ,3 ]
Rodes-Cabau, Josep [4 ]
Holmes, David R., Jr. [5 ]
LeWinter, Martin M. [1 ,2 ]
Dauerman, Harold L. [1 ,2 ]
机构
[1] Univ Vermont, Med Ctr, Div Cardiol, 111 Colchester Ave,McClure 1, Burlington, VT 05401 USA
[2] Univ Vermont, Med Ctr, Cardiovasc Res Inst, Burlington, VT USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Internal Med, Div Cardiovasc Med, Boston, MA USA
[4] Laval Univ, Quebec Heart & Lung Inst, Quebec City, PQ, Canada
[5] Mayo Clin, Coll Med, Dept Cardiovasc Dis, Rochester, MN USA
关键词
aortic stenosis; congestive heart failure; transcatheter aortic valve replacement; LEFT-VENTRICULAR DYSFUNCTION; LONG-TERM OUTCOMES; HIGH-RISK PATIENTS; LOW TRANSVALVULAR GRADIENT; CORONARY-ARTERY-DISEASE; PARTNER TRIAL COHORT; BUNDLE-BRANCH BLOCK; OF-THE-LITERATURE; LOW-FLOW; SYSTOLIC DYSFUNCTION;
D O I
10.1016/j.jacc.2017.10.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk and benefit of mechanical interventions in valvular heart disease have been primarily described among patients with normal ejection fraction. The advent of nonsurgical mechanical interventions for aortic stenosis (transcatheter aortic valve replacement) may alter the risk-benefit ratio for patients who would otherwise be at increased risk for valve surgery. This review describes the epidemiology and pathophysiology of aortic stenosis with heart failure and reduced ejection fraction and summarizes the current registry and clinical trial data applicable to this frequently encountered high-risk group. It concludes with discussion of ongoing trials, new approaches, emerging indications, and a potential clinical algorithm incorporating optimal mechanical intervention for patients with aortic stenosis and concomitant reduced ejection fraction. (c) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:3026 / 3041
页数:16
相关论文
共 50 条
  • [21] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Armstrong, Paul W.
    Pieske, Burkert
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jia, Gang
    McNulty, Steven E.
    Patel, Mahesh J.
    Roessig, Lothar
    Koglin, Joerg
    O'Connor, Christopher M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1883 - 1893
  • [22] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [23] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Volpe, Massimo
    Santolamazza, Caterina
    Tocci, Giuliano
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [24] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [25] Cells in Patients with Heart Failure with Reduced Ejection Fraction
    Lopes, Jose
    Teixeira, Manuel
    Cavalcante, Suiane
    Gouveia, Marisol
    Duarte, Ana
    Ferreira, Miriam
    Simoes, Maria I.
    Conceicao, Maria
    Ribeiro, Ilda P.
    Goncalves, Ana C.
    Schmidt, Cristine
    de Jesus, Bruno Bernardes
    Almeida, Ramiro
    Viamonte, Sofia
    Santos, Mario
    Ribeiro, Fernando
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 289 - 295
  • [26] Benzodiazepines in Patients with Heart Failure and Reduced Ejection Fraction
    Chuang, Chi
    Hsiao, Fu-Chih
    Cheng, Yu-Wen
    Lin, Chia-Pin
    Tung, Ying-Chang
    Wu, Chia-Tung
    Chen, Ching-Yen
    Chu, Pao-Hsien
    ACTA CARDIOLOGICA SINICA, 2022, 38 (05) : 573 - 583
  • [27] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972
  • [28] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Massimo Volpe
    Caterina Santolamazza
    Giuliano Tocci
    Current Cardiology Reports, 2016, 18
  • [29] Heart Failure Preserved Ejection Fraction Patients Benefit From Heart Failure Reduced Ejection Fraction Guidelines
    Steahr, Gregg
    Kelly, Linda
    Moore, Meredith
    Hott, Brenda
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S73 - S74
  • [30] Mortality and Readmissions in Patients With Heart Failure With Preserved Ejection Fraction versus Heart Failure With Reduced Ejection Fraction
    Carcora, Yaser
    Gravely, Amy
    Tholakanahalli, Venkatakrishna N.
    Adabag, Selcuk
    CIRCULATION, 2021, 144